Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted three Sangamo abstracts for presentation at ...

在生命科学的“全球创新中心”波士顿， 全球细胞与基因治疗（CGT）的版图正随着每一项技术突破不断创造与迭代。 这里不仅是基础研究的源头， 更是临床转化与商业创新的极速引擎。 我们诚挚邀请您，加入这场为期一周（5月10日-5月16日）的波士顿国际CGT ...

马萨诸塞州剑桥--(BUSINESS WIRE)--(美国商业资讯)-- 释放RNA药物无限潜力的公司ReNAgade Therapeutics今天宣布，将在2024年5月7-11日于马里兰州巴尔的摩市举行的美国基因与细胞治疗学会(ASGCT)第27届年会上进行口头报告和海报展示，重点介绍支持其全面RNA技术平台的临床前 ...

Kriya’s integrated R&D and manufacturing platform is designed to make gene therapies accessible for more common chronic diseasesASGCT ...

圣犹大儿童研究医院的科学家们将在基因和细胞治疗研究人员专业协会的年度聚会上讨论儿童癌症的细胞治疗研究。 图片:医学博士Ewelina Mamcarz在2018年与Samuel Evangelista一起庆祝，Samuel Evangelista在接受首个慢病毒基因疗法治疗x连锁严重联合免疫缺陷疾病后不久返回 ...

Presentations highlight AI-driven mRNA design process enabling up to 40-fold selectivity and 10-fold in vivo oncoselectivity ...

This presentation marks a critical step toward what KROMATID is building as the world's first genomic intelligence platform - ...

Scribe Therapeutics to highlight engineered CRISPR platform advances and lead cardiometabolic pipeline at ASGCT and EAS Congress 2026 ...

Aptamer Group plc, the leading developer of next-generation synthetic binders delivering innovation to the life science industry, presented new data on its Optimer therapeutic delivery vehicle for ...

Programmable circRNA platform achieves near-complete B cell depletion in non-human primates using targeted in vivo CAR-T deliveryBOSTON--(BUSINESS WIRE)--Strand Therapeutics, a clinical-stage ...

The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing. Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced ...

SAN DIEGO--(BUSINESS WIRE)--Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be presenting preclinical data for its ...